Pediatrix Medical Group Q1 Adj $0.20 Beats $0.19 Estimate, Sales $495.10M Miss $499.08M Estimate
Portfolio Pulse from Benzinga Newsdesk
Pediatrix Medical Group (MD) reported Q1 adjusted earnings of $0.20 per share, surpassing the $0.19 estimate, but its sales of $495.10M fell short of the $499.08M estimate. This represents a 13.04% decrease in earnings per share compared to last year, while sales saw a slight increase of 0.83% from the previous year.
May 07, 2024 | 10:01 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Pediatrix Medical Group's Q1 earnings surpassed estimates, but sales did not meet expectations. Earnings per share decreased by 13.04% YOY, while sales increased slightly by 0.83%.
While MD's earnings per share exceeded expectations, the slight miss in sales forecasts and the decrease in earnings compared to last year could lead to mixed reactions in the short term. The increase in sales YOY indicates some positive momentum, but the decrease in earnings per share might concern investors. Overall, the impact on MD's stock price is likely to be neutral in the short term as positive and negative factors balance each other out.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100